Preventing postoperative recurrence in Crohn's disease with 6-mercaptopurine and azathioprine: approaching the cutting edge

Affiliations

Comment

Alain Bitton. Inflamm Bowel Dis. 2005 May.

. 2005 May;11(5):513-4.

doi: 10.1097/01.mib.0000161535.89789.e9.

¹ Division of Gastroenterology, McGill University Health Centre, Montreal, Canada.

No abstract available

Comment on

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH. Hanauer SB, et al. Gastroenterology. 2004 Sep;127(3):723-9. doi: 10.1053/j.gastro.2004.06.002. Gastroenterology. 2004. PMID: 15362027 Clinical Trial.
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, Imbesi V, Molteni M, Danelli PG, Taschieri AM, Bianchi Porro G. Ardizzone S, et al. Gastroenterology. 2004 Sep;127(3):730-40. doi: 10.1053/j.gastro.2004.06.051. Gastroenterology. 2004. PMID: 15362028 Clinical Trial.